Seminars in Clinical Research |
Type | Seminars in Clinical Research |
Title | RNA Interference: A Research Tool or a New Class of Therapeutics Solving Major Public Health Issues? |
Date | Wednesday, March 27, 2019 |
Time | 12:00 p.m. - 1:00 p.m. |
Location | 301 WRB |
Speaker(s) | Peter Wijngaard, Ph.D., chief development officer, The Medicines Company |
Open To | Tri-Institutional |
Host | Dr. Sarah Schlesinger |
Contact | Michelle Romanick |
Phone | 212-327-7316 |
Readings | http://clinfo.rockefeller.edu/seminar/2015-2018_Seminars_in_Clinical_Research/Ray inclisiran high CV Risk elevated LDL C NEJM 2017.pdf |
Readings | http://clinfo.rockefeller.edu/seminar/2015-2018_Seminars_in_Clinical_Research/Fitzgerald ALN-PSCsc NEJM 11 2016.pdf |